The G-CIMP profile is tightly associated with IDH1/2 mutations and better outcomes for patients with IDH-mutated gliomas (Noushmehr et al., 2010; Malta et al., 2018; Tesileanu et al., 2021). Here, IDH1 is linked to glioma.